CLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Published in the journal Pain Medicine, “Comparison of Percutaneous 60-Day Peripheral Nerve Stimulation of the Lumbar Medial Branches to Usual Care with ...

CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics’ SPRINT PNS System generated interest from leading pain physicians at the American Society of Pain & Neuroscience ...

SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain Under Aetna’s updated medical policy, the SPRINT PNS System ...

CLEVELAND, July 07, 2025 (GLOBE NEWSWIRE) -- Recently, ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS (SPRINT PNS), offering evidence-based best practice ...

- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- ...

CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...

Learn more Medtronic is to acquire SPR Therapeutics for an upfront cash payment of nearly $650m, expanding care options for ...

Medtronic acquire pain management devicemaker SPR Therapeutics for $650M to expand neuromodulation with peripheral nerve stimulation technology.